海王生物(000078) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was ¥10,537,255,907.17, representing a decrease of 3.15% compared to the same period last year[4] - Net profit attributable to shareholders was ¥73,472,504.04, an increase of 1.75% year-on-year[4] - Net profit excluding non-recurring gains and losses decreased by 49.66% to ¥60,757,670.24[4] - Total operating revenue for the current period reached CNY 30,775,630,066.91, an increase of 7.07% compared to CNY 28,745,122,185.02 in the previous period[25] - Net profit for the current period was CNY 351,745,607.06, a decrease of 17.3% from CNY 425,194,981.82 in the previous period[25] - The net profit attributable to the parent company was CNY 213,690,647.41, compared to CNY 200,337,612.75 in the previous period, showing an increase of 6.7%[28] - The total comprehensive income for the current period was CNY 350,804,049.56, down from CNY 425,194,981.82 in the previous period[28] Cash Flow - Operating cash flow for the year-to-date increased significantly by 550.45% to ¥1,130,606,278.79[4] - Cash flow from operating activities increased to ¥1,130,606,278.79, compared to ¥173,819,313.43 in the previous period, representing a significant growth[32] - Cash inflow from operating activities totaled ¥35,647,916,549.00, up from ¥31,738,415,095.93 in the prior period[32] - Cash outflow for purchasing goods and services rose to ¥29,038,219,045.66, compared to ¥25,260,063,059.75 previously[32] - Net cash flow from investing activities was -¥708,547,597.51, an increase in outflow from -¥271,223,689.76 in the last period[35] - Total cash inflow from financing activities decreased to ¥17,350,468,225.70 from ¥20,176,703,830.68[35] - Cash outflow for debt repayment was ¥11,501,856,115.62, slightly down from ¥11,586,181,511.26 in the previous period[35] - The net increase in cash and cash equivalents was -¥1,031,787,153.51, compared to an increase of ¥239,051,524.32 in the last period[35] Assets and Liabilities - Total assets at the end of the reporting period were ¥39,827,938,984.22, a slight increase of 0.27% from the end of the previous year[4] - Total current assets as of September 30, 2021, amounted to ¥33,227,275,736.62, a decrease from ¥33,629,750,978.24 at the end of 2020[19] - Total non-current assets increased to ¥6,600,663,247.60 from ¥6,090,755,548.56 year-over-year[19] - The total liabilities amounted to CNY 32,326,007,777.50, slightly up from CNY 32,230,711,212.40[22] - Current liabilities totaled approximately ¥31.87 billion, which is a significant portion of the total liabilities[41] - Non-current liabilities were reported at approximately ¥359.25 million, with a notable increase in lease liabilities to ¥284.10 million[41] - The total equity attributable to shareholders was approximately ¥5.88 billion, while total equity reached approximately ¥7.49 billion[45] Shareholder Information - Total number of common shareholders at the end of the reporting period was 170,277[12] - The largest shareholder, Shenzhen Haiwang Group, holds 44.22% of shares, totaling 1,216,445,128 shares[12] - The total equity attributable to shareholders of the parent company was CNY 5,924,245,326.29, an increase from CNY 5,878,794,515.68[22] Research and Development - The company reported a 40.63% increase in R&D expenses, reflecting increased investment in research and development[8] - Research and development expenses increased to CNY 48,647,713.09 from CNY 34,593,150.85, representing a growth of 40.6%[25] Financial Position - The company has a total of ¥2.44 billion in notes payable and ¥8.29 billion in accounts payable, reflecting substantial short-term obligations[41] - The company reported a retained earnings of approximately ¥891.45 million, indicating a strong profit retention strategy[45] - The capital reserve stands at approximately ¥2.46 billion, with treasury stock amounting to ¥275.12 million[45] - The company has a deferred income tax liability of approximately ¥2.41 million, indicating potential future tax obligations[41] Audit Status - The company has not undergone an audit for the third quarter report, which may affect the reliability of the financial data presented[46]